Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005739 | mitochondrion | 5 | 2 |
GO:0043226 | organelle | 2 | 2 |
GO:0043227 | membrane-bounded organelle | 3 | 2 |
GO:0043229 | intracellular organelle | 3 | 2 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 2 |
GO:0110165 | cellular anatomical entity | 1 | 2 |
Related structures:
AlphaFold database: Q4Q5F2
Term | Name | Level | Count |
---|---|---|---|
GO:0006412 | translation | 4 | 12 |
GO:0006518 | peptide metabolic process | 4 | 12 |
GO:0006807 | nitrogen compound metabolic process | 2 | 12 |
GO:0008152 | metabolic process | 1 | 12 |
GO:0009058 | biosynthetic process | 2 | 12 |
GO:0009059 | macromolecule biosynthetic process | 4 | 12 |
GO:0009987 | cellular process | 1 | 12 |
GO:0018193 | peptidyl-amino acid modification | 5 | 2 |
GO:0018206 | peptidyl-methionine modification | 6 | 2 |
GO:0019538 | protein metabolic process | 3 | 12 |
GO:0031365 | N-terminal protein amino acid modification | 5 | 2 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 12 |
GO:0034645 | obsolete cellular macromolecule biosynthetic process | 4 | 12 |
GO:0036211 | protein modification process | 4 | 2 |
GO:0043043 | peptide biosynthetic process | 5 | 12 |
GO:0043170 | macromolecule metabolic process | 3 | 12 |
GO:0043412 | macromolecule modification | 4 | 2 |
GO:0043603 | amide metabolic process | 3 | 12 |
GO:0043604 | amide biosynthetic process | 4 | 12 |
GO:0043686 | co-translational protein modification | 5 | 2 |
GO:0044237 | cellular metabolic process | 2 | 12 |
GO:0044238 | primary metabolic process | 2 | 12 |
GO:0044249 | cellular biosynthetic process | 3 | 12 |
GO:0044260 | obsolete cellular macromolecule metabolic process | 3 | 12 |
GO:0044271 | cellular nitrogen compound biosynthetic process | 4 | 12 |
GO:0071704 | organic substance metabolic process | 2 | 12 |
GO:1901564 | organonitrogen compound metabolic process | 3 | 12 |
GO:1901566 | organonitrogen compound biosynthetic process | 4 | 12 |
GO:1901576 | organic substance biosynthetic process | 3 | 12 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 12 |
GO:0005488 | binding | 1 | 12 |
GO:0016787 | hydrolase activity | 2 | 12 |
GO:0016810 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds | 3 | 12 |
GO:0016811 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides | 4 | 12 |
GO:0042586 | peptide deformylase activity | 5 | 12 |
GO:0043167 | ion binding | 2 | 12 |
GO:0043169 | cation binding | 3 | 12 |
GO:0046872 | metal ion binding | 4 | 12 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 2 | 4 | PF00675 | 0.589 |
CLV_NRD_NRD_1 | 51 | 53 | PF00675 | 0.274 |
CLV_NRD_NRD_1 | 8 | 10 | PF00675 | 0.598 |
CLV_PCSK_KEX2_1 | 2 | 4 | PF00082 | 0.587 |
CLV_PCSK_KEX2_1 | 51 | 53 | PF00082 | 0.274 |
CLV_PCSK_KEX2_1 | 8 | 10 | PF00082 | 0.585 |
CLV_PCSK_SKI1_1 | 197 | 201 | PF00082 | 0.306 |
CLV_PCSK_SKI1_1 | 59 | 63 | PF00082 | 0.253 |
DEG_Nend_UBRbox_1 | 1 | 4 | PF02207 | 0.565 |
DEG_SPOP_SBC_1 | 28 | 32 | PF00917 | 0.583 |
DOC_CKS1_1 | 232 | 237 | PF01111 | 0.349 |
DOC_PP4_FxxP_1 | 97 | 100 | PF00568 | 0.262 |
DOC_USP7_MATH_1 | 28 | 32 | PF00917 | 0.502 |
DOC_USP7_MATH_1 | 57 | 61 | PF00917 | 0.324 |
DOC_WW_Pin1_4 | 231 | 236 | PF00397 | 0.420 |
DOC_WW_Pin1_4 | 29 | 34 | PF00397 | 0.473 |
DOC_WW_Pin1_4 | 72 | 77 | PF00397 | 0.281 |
LIG_14-3-3_CanoR_1 | 162 | 168 | PF00244 | 0.347 |
LIG_Actin_WH2_2 | 36 | 53 | PF00022 | 0.398 |
LIG_BIR_III_4 | 23 | 27 | PF00653 | 0.433 |
LIG_BRCT_BRCA1_1 | 31 | 35 | PF00533 | 0.501 |
LIG_BRCT_BRCA1_1 | 74 | 78 | PF00533 | 0.351 |
LIG_FHA_1 | 13 | 19 | PF00498 | 0.589 |
LIG_FHA_1 | 152 | 158 | PF00498 | 0.340 |
LIG_FHA_1 | 60 | 66 | PF00498 | 0.340 |
LIG_FHA_1 | 68 | 74 | PF00498 | 0.340 |
LIG_FHA_2 | 116 | 122 | PF00498 | 0.359 |
LIG_LIR_Apic_2 | 121 | 126 | PF02991 | 0.247 |
LIG_LIR_Apic_2 | 96 | 100 | PF02991 | 0.262 |
LIG_Pex14_1 | 221 | 225 | PF04695 | 0.339 |
LIG_SH2_SRC | 168 | 171 | PF00017 | 0.274 |
LIG_SH2_STAP1 | 120 | 124 | PF00017 | 0.334 |
LIG_SH2_STAP1 | 256 | 260 | PF00017 | 0.419 |
LIG_SH2_STAT5 | 219 | 222 | PF00017 | 0.266 |
LIG_SH2_STAT5 | 231 | 234 | PF00017 | 0.367 |
LIG_SH2_STAT5 | 241 | 244 | PF00017 | 0.377 |
LIG_SH3_3 | 123 | 129 | PF00018 | 0.262 |
LIG_SH3_3 | 154 | 160 | PF00018 | 0.247 |
LIG_SH3_3 | 229 | 235 | PF00018 | 0.394 |
LIG_SH3_3 | 244 | 250 | PF00018 | 0.286 |
LIG_SH3_3 | 61 | 67 | PF00018 | 0.308 |
LIG_SUMO_SIM_par_1 | 107 | 113 | PF11976 | 0.295 |
LIG_TRAF2_2 | 235 | 240 | PF00917 | 0.307 |
MOD_CDK_SPxxK_3 | 29 | 36 | PF00069 | 0.465 |
MOD_CK1_1 | 149 | 155 | PF00069 | 0.323 |
MOD_CK1_1 | 31 | 37 | PF00069 | 0.561 |
MOD_CK2_1 | 115 | 121 | PF00069 | 0.376 |
MOD_CK2_1 | 31 | 37 | PF00069 | 0.532 |
MOD_GlcNHglycan | 165 | 168 | PF01048 | 0.250 |
MOD_GlcNHglycan | 226 | 229 | PF01048 | 0.327 |
MOD_GlcNHglycan | 97 | 100 | PF01048 | 0.262 |
MOD_GSK3_1 | 27 | 34 | PF00069 | 0.592 |
MOD_GSK3_1 | 68 | 75 | PF00069 | 0.320 |
MOD_N-GLC_1 | 243 | 248 | PF02516 | 0.434 |
MOD_NEK2_1 | 110 | 115 | PF00069 | 0.295 |
MOD_NEK2_1 | 195 | 200 | PF00069 | 0.325 |
MOD_NEK2_1 | 208 | 213 | PF00069 | 0.249 |
MOD_NEK2_1 | 78 | 83 | PF00069 | 0.276 |
MOD_NEK2_1 | 95 | 100 | PF00069 | 0.338 |
MOD_PIKK_1 | 68 | 74 | PF00454 | 0.317 |
MOD_PKA_2 | 161 | 167 | PF00069 | 0.390 |
MOD_Plk_1 | 243 | 249 | PF00069 | 0.427 |
MOD_Plk_4 | 13 | 19 | PF00069 | 0.568 |
MOD_Plk_4 | 195 | 201 | PF00069 | 0.247 |
MOD_Plk_4 | 243 | 249 | PF00069 | 0.424 |
MOD_Plk_4 | 78 | 84 | PF00069 | 0.360 |
MOD_ProDKin_1 | 231 | 237 | PF00069 | 0.418 |
MOD_ProDKin_1 | 29 | 35 | PF00069 | 0.470 |
MOD_ProDKin_1 | 72 | 78 | PF00069 | 0.281 |
MOD_SUMO_rev_2 | 34 | 43 | PF00179 | 0.544 |
TRG_DiLeu_BaEn_1 | 190 | 195 | PF01217 | 0.378 |
TRG_ER_diArg_1 | 1 | 3 | PF00400 | 0.634 |
TRG_ER_diArg_1 | 182 | 185 | PF00400 | 0.260 |
TRG_ER_diArg_1 | 50 | 52 | PF00400 | 0.274 |
TRG_ER_diArg_1 | 7 | 9 | PF00400 | 0.634 |
TRG_Pf-PMV_PEXEL_1 | 185 | 190 | PF00026 | 0.262 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1I4A0 | Leptomonas seymouri | 73% | 99% |
A0A0S4KJX6 | Bodo saltans | 55% | 98% |
A0A1X0NUS7 | Trypanosomatidae | 65% | 100% |
A0A3R7P233 | Trypanosoma rangeli | 62% | 100% |
A0A3S7X5G9 | Leishmania donovani | 96% | 100% |
A4HKB8 | Leishmania braziliensis | 84% | 100% |
A4I7U7 | Leishmania infantum | 96% | 100% |
D0AA05 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 65% | 100% |
E9B2Q5 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 93% | 100% |
Q9HBH1 | Homo sapiens | 28% | 100% |
V5B173 | Trypanosoma cruzi | 64% | 100% |